As people continue to adapt to the “new normal,” the shift means trading in class and work for Zoom meetings, in-person gatherings to online events and spending more time under the sun.
According to the Centers for Disease Control (CDC), about 1.8 million people aged 40 and above are living with age-related macular degeneration (AMD) in the United States. The CDC also said AMD is the leading cause of permanent impairment of reading or...
Supplementation with lutein and zeaxanthin is a cheap and effective way to cut healthcare spending costs associated with treating age-related macular degeneration, finds a new report from Frost & Sullivan.
A formula supplement containing anti-oxidants plus zinc appears to be cost-effective in slowing the progression of the ‘wet’ form of the most common degenerative eye disease, finds a new study in British Journal of Ophthalmology.
An article published last week in Cochrane Reviews that concludes lutein and zeaxanthin have little effect on the progression of AMD drew a strong reaction from researchers and suppliers in the field.
Researchers in Ireland have concluded via a long term trial that supplementation with three carotenoids—lutein, zeaxanthin and meso-zeaxanthin—can improve the visual performance of subjects who had normal vision to start.
Increased levels of lutein and zeaxanthin are associated with a whopping 40% reduced risk of advanced age-related macular degeneration (AMD), according to researchers from Harvard and Brown.
Sustained supplementation with the macular carotenoids can lead to greater augmentation of macular pigment and improve contrast sensitivity, says a new study.
Supplements of zeaxanthin with or without lutein may boost macular pigment optical density (MPOD) and visual processing speed in young adults, says a new study.
Two years of supplementation with lutein and zeaxanthin may boost macular pigment optical density (MPOD) and retinal sensitivity in people with early age-related macular degeneration (AMD), says a new study.
Lutein and zeaxanthin may boost visual processing speed even in young people at their peak, says a new study that ties together the eye and brain health benefits of the carotenoids.
Two years ago lutein player Kemin said it was, “baffled and annoyed” when EFSA rejected its eye health claim that was already approved in France. This week the EU’s food science agency has done it again, but Kemin and its lutein partner DSM, say they...
The discourse around eye health carotenoid meso-zeaxanthin (MZ) has been marred by commercial interests, according to supplement firm OmniActive Health Technologies.
The significant benefits of adding lutein and zeaxanthin to the AREDS formula for people with low dietary intakes of the carotenoids is an ‘important message’, especially since a large portion of the population has low levels, says the COO of OmniActive.
Adding lutein, zeaxanthin and/or omega-3 fatty acids to the AREDS eye health formula may not offer any additional benefits regarding age-related macular degeneration (AMD) risk, says the much anticipated AREDS2 data.
A combination of lutein, zeaxanthin and omega-3 long-chain polyunsaturated fatty acids may boost the pigment in the retina and help people with age-related macular degeneration (AMD), says new data from Germany.
By Richard Roberts, PhD; Justin Green, PhD; Samanta Maci, MS. Kemin
The statement by eye health researchers that all three carotenoids found in the macula may be needed in a formulation to boost levels of these carotenoids in the macula is 'premature', say leading scientists from Kemin.
A combination of three carotenoids - lutein, zeaxanthin and meso-zeaxanthin – may be needed to boost retinal levels and support eye health, suggests new data from Ireland and the UK.
Dietary supplements of vitamin D3 may boost visual function in lab mice, suggests a new study from the UK with potential implications for the eye health market.
Lutein partners DSM and Kemin may submit an article 13.5 lutein-eye health claim dossier after the European Food Safety Authority (EFSA) this week rejected the carotenoid for the third time – but first they want EFSA to explain why it changed the claim...
A combination of three carotenoids - lutein, zeaxanthin and meso-zeaxanthin – may be needed for eye health benefits in people with abnormal retinal pigmentation, suggests new data from Ireland.
Supplements of zeaxanthin may increase the macula pigment optical density (MPOD) as much as lutein, and boost the functioning of cones in retina, says a new study.
High dietary intake of lutein and zeaxanthin, compounds with a long history of eye health benefits, may reduce the risk of late-stage age-related macular degeneration (AMD), but they show little effect in the early stages of the disease, claims a new...
The Zeaxanthin Trade Association has developed and published a new analytical method to test the purity of zeaxanthin used in foods and dietary supplements, the association has said.
In the second part of our special series on eye health, NutraIngredients takes a closer look at the science behind lutein, omega-3 and the other ingredients eyeing a place on the podium for eye health.
Oxygenated carotenoids, lutein and zeaxanthin, supplied from the diet benefit eye health, according to a new study published in the Institute of Food Technologists’ Journal of Food Science.
Increased intakes of omega-3 fatty acids may reduce the risk of developing age-related blindness by 30 per cent, says a new study from the US National Eye Institute.
A group of zeaxanthin suppliers have united to form the Zeaxanthin Trade Association to increase global awareness of the eye health nutrient and adopt quality standards.
UK supplements manufacturer, Nature’s Best, has been rapped for making unsubstantiated claims that food supplements containing 10mg of lutein and berry extracts can protect the eyes.
A combination of antioxidant pigments and vitamins may slow down sight loss in elderly people, according to researchers from Queen’s University, Belfast.
The European market for eye health supplements is poised to take off, and well-positioned products are set to benefit from a rise in consumer interest, according to market researcher Frost & Sullivan.
The use of rising eye health phytonutrient, zeaxanthin, in food
supplements in doses of up to 20mg has been rejected by the
European Food Safety Authority (EFSA).
Rising eye-health ingredient zeaxanthin has been launched in a
tablet-friendly form by one of the world's big three players -
Illinois-based Chrysantis.
Ingredient group ZMC has been granted a lutein and zeaxanthin
patent, which the company hopes will help position it as a leading
global supplier for the two dietary supplement ingredients.
Higher intakes of the carotenoids lutein and zeaxanthin in the diet
may slash the risk of age-related macular degeneration by 65 per
cent, suggests a new study from Down Under.
Supplements of antioxidants and carotenoids may improve retinal
health in people with age-related macular degeneration (AMD),
suggesting a role beyond prevention, suggests a new study from
Italy.
Kemin has announced a deal with DSM to strengthen an agreement to
supply lutein aimed at eye health around the world, which will see
DSM step up supply of FloraGLO.
Chrysantis announced its branded zeaxanthin has achieved Generally
Regarded As Safe (GRAS) status, opening up the potential for the
ingredient to be used in a new category of functional food and
beverages.
Supplementing with lutein and zeaxanthin has once again been
associated with a lower risk for age-related macular degeneration,
according to a new report.
Vitiva is introducing a lutein ester ingredient extracted from
marigold flowers that is being aimed at enabling higher
dosages in dietary supplements in the US and Europe.
A new human study has shown that Cognis' Xangold lutein and
zeaxanthin ingredient is effective at boosting the eye health of
those with early-stage age-related macular degeneration (AMD).
A stable intake of the carotenoids, lutein and zeaxanthin, could
reduce the risk of age related macular degeneration by 43 per cent
in women under 75, says a new cohort study.
